Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells
- PMID:9529167
- DOI: 10.1161/01.res.82.5.619
Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells
Abstract
Angiotensin II (Ang II) plays a role in the development of many vascular diseases. In the present study, we have investigated the effect of Ang II on vascular endothelial growth factor (VEGF) receptor expression and VEGF-induced angiogenic activity in bovine retinal microcapillary endothelial cells (BRECs). Ang II induced a significant increase of kinase domain-containing receptor/total liver kinase (KDR/Flk-1) mRNA in a time- and dose-dependent manner, with a maximal 4.3+/-0.8-fold increase after a 4-hour stimulation. Ang II increased the rate of KDR gene transcription by 5.4-fold, whereas the half-life of KDR mRNA was not increased significantly. The increase depended partially on new protein synthesis. The Ang II-induced KDR mRNA increase was inhibited by either [Sar1,Ile8]angiotensin or angiotensin type 1 receptor antagonists but was not significantly altered by angiotensin type 2 receptor antagonists. The PKC inhibitor reduced Ang II-induced KDR mRNA expression by 70+/-15%. The tyrosine kinase inhibitor reduced the Ang II- and phorbol 12-myristate 13-acetate-induced KDR mRNA increases by 35+/-8% and 44+/-26%, respectively. Ang II increased by 3.1-fold the 35S-labeled KDR/Flk-1 immunoprecipitated by a specific antibody to KDR/Flk-1. Scatchard analysis demonstrated that Ang II induced a significant increase of binding sites without changing binding affinity. Ang II enhanced VEGF-induced cell growth and tube formation. Ang II itself had no effect on cell growth, tube formation, or mRNA levels of VEGF and tms-like tyrosine kinase (Flt-1) in BRECs. These findings suggest that Ang II might potentiate VEGF-induced angiogenic activity through an increase of the VEGF receptor KDR/Flk-1.
Similar articles
- Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway.Hata Y, Rook SL, Aiello LP.Hata Y, et al.Diabetes. 1999 May;48(5):1145-55. doi: 10.2337/diabetes.48.5.1145.Diabetes. 1999.PMID:10331422
- Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide.Wang J, Morita I, Onodera M, Murota SI.Wang J, et al.J Cell Physiol. 2002 Feb;190(2):238-50. doi: 10.1002/jcp.10059.J Cell Physiol. 2002.PMID:11807828
- Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells.Takagi H, King GL, Ferrara N, Aiello LP.Takagi H, et al.Invest Ophthalmol Vis Sci. 1996 Jun;37(7):1311-21.Invest Ophthalmol Vis Sci. 1996.PMID:8641834
- [Regulation of the endothelial function and angiogenesis by vascular endothelial growth factor-A (VEGF-A].Kroll J, Waltenberger J.Kroll J, et al.Z Kardiol. 2000 Mar;89(3):206-18. doi: 10.1007/s003920050472.Z Kardiol. 2000.PMID:10798277Review.German.
- Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy.Witte L, Hicklin DJ, Zhu Z, Pytowski B, Kotanides H, Rockwell P, Böhlen P.Witte L, et al.Cancer Metastasis Rev. 1998 Jun;17(2):155-61. doi: 10.1023/a:1006094117427.Cancer Metastasis Rev. 1998.PMID:9770111Review.
Cited by
- Aldose reductase inhibitor ameliorates renal vascular endothelial growth factor expression in streptozotocin-induced diabetic rats.Sung JK, Koh JH, Lee MY, Kim BH, Nam SM, Kim JH, Yoo JH, Kim SH, Hong SW, Lee EY, Choi R, Chung CH.Sung JK, et al.Yonsei Med J. 2010 May;51(3):385-91. doi: 10.3349/ymj.2010.51.3.385.Yonsei Med J. 2010.PMID:20376891Free PMC article.
- Microarray analysis for genes associated with angiogenesis in diabetic OLETF keratocytes.Park JM, Park YM, Jung W, Lee JE, Lee JS.Park JM, et al.J Korean Med Sci. 2014 Feb;29(2):265-71. doi: 10.3346/jkms.2014.29.2.265. Epub 2014 Jan 28.J Korean Med Sci. 2014.PMID:24550656Free PMC article.
- Exposure to ACEI/ARB and β-Blockers Is Associated with Improved Survival and Decreased Tumor Progression and Hospitalizations in Patients with Advanced Colon Cancer.Engineer DR, Burney BO, Hayes TG, Garcia JM.Engineer DR, et al.Transl Oncol. 2013 Oct 1;6(5):539-45. doi: 10.1593/tlo.13346. eCollection 2013.Transl Oncol. 2013.PMID:24151534Free PMC article.
- AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.Alhusban A, Kozak A, Ergul A, Fagan SC.Alhusban A, et al.J Pharmacol Exp Ther. 2013 Feb;344(2):348-59. doi: 10.1124/jpet.112.197483. Epub 2012 Dec 4.J Pharmacol Exp Ther. 2013.PMID:23211364Free PMC article.
- [Expression of angiotensin I converting enzyme in pulmonary hypertension].Müller AM, Maas M, Kozianka U, Franke FE.Müller AM, et al.Pathologe. 2006 Mar;27(2):133-9. doi: 10.1007/s00292-006-0820-7.Pathologe. 2006.PMID:16453109German.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Miscellaneous